Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Long‐acting beta2‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta2‐agonist alone for chronic obstructive pulmonary disease

Esta versión no es la más reciente

ver la versión actual 22 octubre 2015

Información

DOI:
https://doi.org/10.1002/14651858.CD008989.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 abril 2012see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Vías respiratorias

Copyright:
  1. Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Charlotta Karner

    Correspondencia a: BMJ‐TAG, BMJ, London, UK

    [email protected]

  • Christopher J Cates

    Population Health Research Institute, St George's, University of London, London, UK

Contributions of authors

Charlotta Karner assessed studies for inclusion, extracted data, conducted the analysis and wrote the review with input from Chris Cates.

Sources of support

Internal sources

  • St George's University of London, UK.

External sources

  • NIHR, UK.

    Programme grant funding

Declarations of interest

None known

Acknowledgements

We are grateful to Elizabeth Stovold for help in designing the search strategy, Elora Baishnab for going through the search and extracting data for relevant studies, and Steven Edwards for his feedback on incorporation of an economic perspective in the review.

CRG Funding Acknowledgement: The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Airways Group.

Disclaimer: The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2015 Oct 22

Long‐acting beta<sub>2</sub>‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta<sub>2</sub>‐agonist alone for chronic obstructive pulmonary disease

Review

Hugo A Farne, Christopher J Cates

https://doi.org/10.1002/14651858.CD008989.pub3

2012 Apr 18

Long‐acting beta<sub>2</sub>‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta<sub>2</sub>‐agonist alone for chronic obstructive pulmonary disease

Review

Charlotta Karner, Christopher J Cates

https://doi.org/10.1002/14651858.CD008989.pub2

2011 Feb 16

Long‐acting beta<sub>2</sub>‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta<sub>2</sub>‐agonist alone for chronic obstructive pulmonary disease

Protocol

Charlotta Karner, Christopher J Cates

https://doi.org/10.1002/14651858.CD008989

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.